About Medical Technology Policy Institute (MTPI)
- HOME
- About AMDD
- About Medical Technology Policy Institute (MTPI)
About Medical Technology Policy Institute (MTPI)
AMDD aims the prompt and appropriate introduction of advanced medical technologies in medical practice, evaluation of innovation, and suitable distribution of medical expenses. To achieve these goals, the institute’s mission is to conduct research from a mid-to-long-term perspective and provide policy recommendations for medical devices, in-vitro diagnostics (IVD), and other medical technologies to make greater contributions to Japanese medical care.
AMDD maintains a close collaborative relationship with our stakeholders including the Ministry of Health, Labour and Welfare, and seeks to give recommendations on how medical devices and IVD can make greater contributions to Japanese medical care. We greatly appreciate your kind support.
Makoto Tamura
Director, Medical Technology Policy Institute (MTPI)
Organization
- Director
- Makoto Tamura
- Founder and CEO, Healthcare System Planning Institute
Research Professor, Graduate school of International University of Health and Welfare - Bio
- Special Advisor
- Kohei Onozaki
- Board Member Health and Global Policy Institute
- Bio
- Senior Researcher
- Kosuke Iwasaki
- Principal of healthcare division Milliman Japan
- Bio
Research Performance of MTPI
- Jun.,2024
The Role and Future of Medical Devices in Modernizing Healthcare: Evidence-Based Practice, Enhancing Patient QOL and Productivity, and Treatment Beyond Time and Space - Oct.,2022
Consider the medical insurance application of similar but different products--medical devices and drugs. - Apr., 2022
Co-authored "Medical Device Industry Theory -- Challenges and Prospects Toward a Leading Industry" (Nihon Hyoronsha, Inc.) published in March 2022. - Nov., 2021
Study Group for Realizing "Patient-Centered Medical Care" to Support Patients' Wishes Report Toward the realization of a society in which shared decision-making between healthcare professionals and patients is possible - 10/29/2021
Designated Project "Evaluation and Application of Cost-Effectiveness of Pharmaceuticals and Medical Devices: Current Status and Future Prospects in Japan "Responses from Pharmaceutical and Medical Device Companies" - Aug., 2020
Recommendations from the Study Group on the State of Insurance Reimbursement of Medical Technology, Anticipating Advances in Digital Health (Abbreviation: AI and Digital Health Study Group) - 04/15/2019
Analysis of the relationship between the numbers of CT and MRI devices installed, the number of images taken and medical care expenses - 12/14/2018
Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?
